These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 30602457)
1. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Hutter G; Theruvath J; Graef CM; Zhang M; Schoen MK; Manz EM; Bennett ML; Olson A; Azad TD; Sinha R; Chan C; Assad Kahn S; Gholamin S; Wilson C; Grant G; He J; Weissman IL; Mitra SS; Cheshier SH Proc Natl Acad Sci U S A; 2019 Jan; 116(3):997-1006. PubMed ID: 30602457 [TBL] [Abstract][Full Text] [Related]
2. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma. Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840 [TBL] [Abstract][Full Text] [Related]
3. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity. Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806 [TBL] [Abstract][Full Text] [Related]
4. Glioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis. Hu J; Xiao Q; Dong M; Guo D; Wu X; Wang B Front Immunol; 2020; 11():593219. PubMed ID: 33329583 [TBL] [Abstract][Full Text] [Related]
6. LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization. Hu J; Dong F; He Y; Xia X; Cheng F; Chen S; Hou X; Zhang P; Liu G; Li Y; Gao Q; Dong M; Li T; Li W; Xiao Q; Li X; Yu X; Xi G; Guo D; Wu X; Wang B J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096529 [TBL] [Abstract][Full Text] [Related]
7. Modulation of CD47-SIRPα innate immune checkpoint axis with Fc-function detuned anti-CD47 therapeutic antibody. Narla RK; Modi H; Bauer D; Abbasian M; Leisten J; Piccotti JR; Kopytek S; Eckelman BP; Deveraux Q; Timmer J; Zhu D; Wong L; Escoubet L; Raymon HK; Hariharan K Cancer Immunol Immunother; 2022 Feb; 71(2):473-489. PubMed ID: 34247273 [TBL] [Abstract][Full Text] [Related]
8. Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma. Chen Z; Feng X; Herting CJ; Garcia VA; Nie K; Pong WW; Rasmussen R; Dwivedi B; Seby S; Wolf SA; Gutmann DH; Hambardzumyan D Cancer Res; 2017 May; 77(9):2266-2278. PubMed ID: 28235764 [TBL] [Abstract][Full Text] [Related]
9. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells. Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669 [TBL] [Abstract][Full Text] [Related]
10. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy. Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231 [No Abstract] [Full Text] [Related]
11. Cancer immunotherapy targeting the CD47/SIRPα axis. Weiskopf K Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286 [TBL] [Abstract][Full Text] [Related]
12. A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. Li Y; Yi J; Ma R; Wang Y; Lou X; Dong Y; Cao Y; Li X; Wang M; Dang X; Li R; Lei N; Song H; Qin Z; Yang W J Control Release; 2024 Sep; 373():447-462. PubMed ID: 39038546 [TBL] [Abstract][Full Text] [Related]
13. Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells. Bian Z; Shi L; Guo YL; Lv Z; Tang C; Niu S; Tremblay A; Venkataramani M; Culpepper C; Li L; Zhou Z; Mansour A; Zhang Y; Gewirtz A; Kidder K; Zen K; Liu Y Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5434-43. PubMed ID: 27578867 [TBL] [Abstract][Full Text] [Related]
14. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma. Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621 [TBL] [Abstract][Full Text] [Related]
15. Macrophages and microglia: the cerberus of glioblastoma. Buonfiglioli A; Hambardzumyan D Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119 [TBL] [Abstract][Full Text] [Related]
16. SLIT2/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia. Geraldo LH; Xu Y; Jacob L; Pibouin-Fragner L; Rao R; Maissa N; Verreault M; Lemaire N; Knosp C; Lesaffre C; Daubon T; Dejaegher J; Solie L; Rudewicz J; Viel T; Tavitian B; De Vleeschouwer S; Sanson M; Bikfalvi A; Idbaih A; Lu QR; Lima FR; Thomas JL; Eichmann A; Mathivet T J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34181595 [TBL] [Abstract][Full Text] [Related]
17. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Evans TA; Barkauskas DS; Myers JT; Hare EG; You JQ; Ransohoff RM; Huang AY; Silver J Exp Neurol; 2014 Apr; 254():109-20. PubMed ID: 24468477 [TBL] [Abstract][Full Text] [Related]
18. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes. Gitik M; Liraz-Zaltsman S; Oldenborg PA; Reichert F; Rotshenker S J Neuroinflammation; 2011 Mar; 8():24. PubMed ID: 21401967 [TBL] [Abstract][Full Text] [Related]
19. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130 [TBL] [Abstract][Full Text] [Related]
20. Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages. Zhu N; Chen S; Jin Y; Wang M; Fang L; Xue L; Hua D; Zhang Z; Jia M; Hao M; Zhang C ACS Nano; 2024 Apr; 18(17):11165-11182. PubMed ID: 38626338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]